Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · IEX Real-Time Price · USD
0.865
-0.025 (-2.81%)
At close: Apr 19, 2024, 4:00 PM
0.870
+0.005 (0.58%)
After-hours: Apr 19, 2024, 7:59 PM EDT
Microbot Medical Market Cap
Microbot Medical has a market cap or net worth of $12.46 million as of April 19, 2024. Its market cap has decreased by -15.27% in one year.
Market Cap
12.46M
Enterprise Value
6.25M
1-Year Change
-15.27%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since December 1, 1998, Microbot Medical's market cap has decreased from $25.90M to $12.46M, a decrease of -51.91%. That is a compound annual growth rate of -2.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 19, 2024 | 12.50M | -2.34% |
Apr 18, 2024 | 12.80M | -1.54% |
Apr 17, 2024 | 13.00M | -5.11% |
Apr 16, 2024 | 13.70M | -7.43% |
Apr 15, 2024 | 14.80M | 2.07% |
Apr 12, 2024 | 14.50M | -7.05% |
Apr 11, 2024 | 15.60M | -2.50% |
Apr 10, 2024 | 16.00M | -1.84% |
Apr 9, 2024 | 16.30M | -2.98% |
Apr 8, 2024 | 16.80M | -5.08% |
Apr 5, 2024 | 17.70M | -2.21% |
Apr 4, 2024 | 18.10M | - |
Apr 3, 2024 | 18.10M | 2.84% |
Apr 2, 2024 | 17.60M | -8.33% |
Apr 1, 2024 | 19.20M | 8.47% |
Mar 28, 2024 | 17.70M | 6.63% |
Mar 27, 2024 | 16.60M | 25.76% |
Mar 26, 2024 | 13.20M | -3.65% |
Mar 25, 2024 | 13.70M | -1.44% |
Mar 22, 2024 | 13.90M | 2.96% |
Mar 21, 2024 | 13.50M | 2.27% |
Mar 20, 2024 | 13.20M | 3.13% |
Mar 19, 2024 | 12.80M | - |
Mar 18, 2024 | 12.80M | -1.54% |
Mar 15, 2024 | 13.00M | -1.52% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
XTL Biopharmaceuticals | 13.30M |
Senti Biosciences | 13.27M |
Tonix Pharmaceuticals Holding | 13.27M |
Check-Cap | 13.22M |
Centogene | 12.85M |
Biomerica | 12.78M |
RedHill Biopharma | 12.50M |
Avalo Therapeutics | 12.42M |